Avita Medical is a medical device company that provides a unique approach to skin regeneration



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Our patented and proprietary collection and application technology provides innovative treatment solutions derived from a patient’s own skin to treat a wide range of wounds, scars and skin defects. Our devices create a Regenerative Epithelial Suspension (RES™) – an autologous suspension comprised of the cells and wound healing factors necessary to regenerate natural healthy skin.

Avita’s regenerative product portfolio includes ReCell® for burns aimed at plastic reconstructive procedures, ReGenerCell™ for chronic wounds and ReNovaCell™ for the restoration of pigmentation.

Read more



The Company

Avita Medical is a medical device company that transforms lives through its unique and innovative skin regeneration solutions. We are a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). We develop and distribute highly innovative regenerative products.

Read more


7,694

Procedures

32

Market Approvals

64

Published Papers

ReCell® is a medical device that enables medical professionals to collect cells from a small sample of a patient’s own skin to create a suspension that can regenerate wounds caused by burns.

Highlights

Share Price

Last Trade: 0.08 Last Trade: 1.2799
High: 0.08 High: 1.288
Low: 0.08 Low: 1.2796
Close: 0.08 Close: 1.24
Volume: 190,000 Volume: 1062
Prices are delayed by 20 minutes